Drugs / IVA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04702360 | — | cystic fibrosis | Vertex Pharmaceuticals Incorporated | Approved for marketing | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IVA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04702360 ↗ |
| Route | Oral | “IVA monotablet for oral administration.” NCT04702360 ↗ |